On this page
MBTPS2
membrane bound transcription factor peptidase, site 2
MBTPS2 is located on the short (p) arm of chromosome X, at band Xp22.12. Arm ratio per GRCh38 - banding schematic.
Explore chromosome X in the library →Available at Jeen Health
Clinical tests that include this
Overview
MBTPS2 is located on the X chromosome and encodes membrane-bound transcription factor peptidase site-2, a zinc metalloprotease critical for regulated intramembrane proteolysis. This enzyme works in concert with site-1 protease to release transcription factors from cellular membranes, enabling them to travel to the nucleus and activate gene expression programmes. The protein plays an essential role in maintaining lipid homeostasis by processing sterol regulatory element-binding proteins, which control cholesterol and fatty acid synthesis. Because MBTPS2 follows X-linked inheritance, males carrying pathogenic variants typically exhibit more severe manifestations than heterozygous females, who may show variable expression due to X-inactivation patterns.
What the gene does
The MBTPS2 protein functions as a membrane-anchored metalloprotease that cleaves transmembrane transcription factor precursors within the Golgi apparatus. Following initial cleavage by site-1 protease, MBTPS2 performs a second proteolytic cut that liberates the active transcription factor domain from the membrane, permitting nuclear translocation. This sequential cleavage mechanism is particularly important for sterol regulatory element-binding proteins, which sense cellular cholesterol levels and coordinate lipogenic gene expression in response to metabolic demands. The enzyme also processes activating transcription factor 6 during endoplasmic reticulum stress, contributing to the unfolded protein response that helps cells adapt to accumulation of misfolded proteins. Beyond lipid metabolism, MBTPS2 activity influences cellular differentiation pathways in epithelial tissues, though the complete repertoire of substrate proteins remains an active area of investigation. Disruption of MBTPS2 protease activity impairs the cell's ability to respond appropriately to metabolic signals and environmental stressors.
Video: Genetics 101
Chromosome location
MBTPS2 is located at chromosome band Xp22.12 on the short arm of the X chromosome. This chromosomal region contains numerous genes subject to X-linked inheritance patterns, where males possess only one copy and females carry two copies with potential for X-inactivation. The gene's position near the pseudoautosomal boundary influences recombination patterns during meiosis.
Protein structure
The MBTPS2 protein comprises 519 amino acids forming a multi-pass transmembrane metalloprotease anchored in the Golgi membrane. The catalytic core contains conserved zinc-binding motifs characteristic of the M50 peptidase family, positioning the active site within the membrane bilayer to access substrate cleavage sites. A disordered region spanning amino acids 115 to 135 likely provides flexibility for substrate recognition and conformational changes during the catalytic cycle. Multiple transmembrane helices anchor the protein and orient the catalytic domain appropriately for processing membrane-tethered transcription factor precursors after initial cleavage by site-1 protease.
Key variants
Pathogenic variants in MBTPS2 predominantly comprise missense changes affecting the catalytic domain, though frameshift and nonsense variants have also been reported. These alterations typically impair protease activity rather than completely abolishing protein expression, resulting in defective processing of substrate transcription factors. The X-linked nature of MBTPS2 means males with pathogenic variants express the condition, whilst carrier females may show mild features or remain unaffected depending on X-inactivation patterns in relevant tissues.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1286G>A | p.Arg429His | Pathogenic | ★★☆☆ | IFAP syndrome 1, with or without BRESHECK syndrome |
c.1523A>G | p.Asn508Ser | Pathogenic | ★★☆☆ | not provided |
c.970+5G>A | - | Pathogenic | ★★☆☆ | IFAP syndrome 1, with or without BRESHECK syndrome |
c.1376A>G | p.Asn459Ser | Pathogenic | ★☆☆☆ | Osteogenesis imperfecta, type 19 |
c.758G>C | p.Gly253Ala | Pathogenic | ★☆☆☆ | not provided |
c.1313C>T | p.Pro438Leu | Pathogenic | - | Hypercholesterolemia, familial, 1 |
c.1391T>C | p.Phe464Ser | Pathogenic | - | Olmsted syndrome, X-linked |
c.1499G>A | p.Gly500Asp | Pathogenic/Likely pathogenic | - | not provided |
c.1515G>C | p.Leu505Phe | Pathogenic | - | Osteogenesis imperfecta, type 19 |
c.671-9T>G | - | Pathogenic | - | IFAP syndrome 1, with or without BRESHECK syndrome |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
MBTPS2 variants are principally associated with Olmsted syndrome, a rare keratinisation disorder characterised by transgressive palmoplantar keratoderma and periorificial keratotic plaques affecting the mouth, nose, and anogenital regions. Affected individuals often experience severe itching, painful fissuring of thickened skin, and complications including alopecia and nail dystrophy. Some MBTPS2 variants have been linked to related but phenotypically distinct conditions involving keratoderma, ichthyosis, or ectodermal dysplasia features, suggesting the gene plays broader roles in epithelial differentiation and barrier function beyond its canonical metabolic functions.
- Olmsted syndrome Dedicated page coming soon
Inheritance pattern
Conditions caused by pathogenic MBTPS2 variants typically follow x-linked inheritance.
X-linked recessive: sons of a carrier mother have a 50% chance of being affected. Daughters have a 50% chance of being carriers.
UK clinical status
MBTPS2 appears on multiple NHS Genomic Medicine Service gene panels reflecting its relevance to diverse clinical presentations. The gene holds green classification status on the ectodermal dysplasia panel (R163), palmoplantar keratodermas panel (R166), and familial cicatricial alopecia panel, indicating strong evidence for clinical validity in these contexts. MBTPS2 also features on the intellectual disability panel (R29), clefting panel, and foetal anomalies panel (R21), recognising that some pathogenic variants may present with syndromic features extending beyond isolated skin findings.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
Why does MBTPS2 primarily affect skin if it regulates lipid metabolism?
Whilst MBTPS2 does regulate sterol response pathways in many cell types, epithelial tissues appear particularly sensitive to disrupted protease activity, possibly because barrier formation and keratinocyte differentiation depend heavily on precise lipid composition and cellular stress responses. The mechanisms linking metabolic protease defects to severe keratoderma remain under investigation.
Do female carriers of MBTPS2 variants develop symptoms?
Females carrying one pathogenic MBTPS2 variant may exhibit mild skin changes or remain asymptomatic, depending on which X chromosome is preferentially inactivated in skin cells. Skewed X-inactivation favouring the chromosome with the pathogenic variant can occasionally produce features resembling affected males, though typically less severe.
Is Olmsted syndrome the only condition caused by MBTPS2 variants?
Olmsted syndrome represents the most recognised MBTPS2-associated disorder, but variants in this gene have been linked to other keratinisation abnormalities including ichthyosis follicularis with atrichia and photophobia syndrome, as well as cases presenting with ectodermal dysplasia features, suggesting a spectrum of related phenotypes.